AXIM Biotechnologies Market Cap

AXIM Biotechnologies has a market cap or net worth of $3.81 million as of April 26, 2024. Its market cap has decreased by -44.64% in one year.

Market Cap

3.81M

Enterprise Value

9.62M

1-Year Change

-44.64%

Ranking

n/a

Market Cap Chart

Since April 29, 2019, AXIM Biotechnologies's market cap has decreased from $78.25M to $3.81M, a decrease of -95.13%. That is a compound annual growth rate of -45.39%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	2.94M	18.93%
Apr 24, 2024	2.47M	-5.50%
Apr 23, 2024	2.62M	-14.17%
Apr 22, 2024	3.05M	-15.33%
Apr 19, 2024	3.60M	-3.23%
Apr 18, 2024	3.72M	-
Apr 17, 2024	3.72M	17.78%
Apr 16, 2024	3.16M	-11.03%
Apr 15, 2024	3.55M	6.85%
Apr 12, 2024	3.32M	22.49%
Apr 11, 2024	2.71M	-1.02%
Apr 10, 2024	2.74M	2.61%
Apr 9, 2024	2.67M	-8.00%
Apr 8, 2024	2.90M	9.65%
Apr 5, 2024	2.65M	-8.80%
Apr 4, 2024	2.90M	-6.02%
Apr 3, 2024	3.09M	29.13%
Apr 2, 2024	2.39M	-10.43%
Apr 1, 2024	2.67M	-
Mar 28, 2024	2.67M	-53.07%
Mar 27, 2024	5.69M	-3.25%
Mar 26, 2024	5.89M	-5.38%
Mar 25, 2024	6.22M	-2.07%
Mar 22, 2024	6.35M	5.02%
Mar 21, 2024	6.05M	0.32%

View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	696.15B
Novo Nordisk	573.09B
UnitedHealth Group	449.26B
Johnson & Johnson	358.00B
Merck & Co.	321.65B
AbbVie	297.12B
AstraZeneca	220.71B
Thermo Fisher	220.40B

Market Cap Rankings